HealthLeaders Media

Infographic: Are Drug Companies or Hospitals More Likely to Violate 340B Rules?

In a recent analysis of HRSA data, the American Hospital Association has turned the tables on drug companies and accused them of being far more likely to violate 340B Drug Pricing Program rules. In ...
HealthLeaders Media

Infographic: 4 Stats on the 340B Drug Pricing Program

Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy (R-Louisiana) recently released the results of an investigation into the 340B Drug Pricing Program. Here are four key ...
BioTechniques

Infographic: Key trends in the transition from animal to patient-derived in vitro models for drug discovery

For our Spotlight on patient-derived in vitro cell models, we surveyed our audience to find out the latest trends, opinions and behaviors in the field. This infographic summarizes the results from the ...
BioTechniques

Infographic: Integrating new approach methodologies into your therapeutics development research

New approach methodologies (NAMs) aim to streamline early-stage drug discovery and revolutionize preclinical testing by replacing traditional animal-based models with human-relevant insights, directly ...